AIPL1 and respiratory distress syndrome in premature infants: While the possibility of various treatment options for IRDs was described previously (for example, translational readthrough-inducing drug [144], photoreceptor transplantation [178], and gene editing [13]), in this review, we will focus only on the already existing AAV-based vectors for AIPL1-associated RD.